MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,938 Cr | ₹2,007 Cr | ₹1,941 Cr | ₹1,310 Cr | ₹1,453 Cr |
What is the latest Profit After Tax of MANKIND PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹1,938 Cr |
| Mar2025 | ₹2,007 Cr |
| Mar2024 | ₹1,941 Cr |
| Mar2023 | ₹1,310 Cr |
| Mar2022 | ₹1,453 Cr |
How is Profit After Tax of MANKIND PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,938 Cr | -3.41 | |
| Mar2025 | ₹2,007 Cr | 3.39 | |
| Mar2024 | ₹1,941 Cr | 48.19 | |
| Mar2023 | ₹1,310 Cr | -9.86 | |
| Mar2022 | ₹1,453 Cr | - | |
Compare Profit After Tax of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹94,040.1 Cr | -1.9% | -5.8% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.9% |
-5.8% |
-12.9% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses